Results 291 to 300 of about 44,802 (314)

Antiarrhythmics

Reactions Weekly, 2021
openaire   +2 more sources

Class I antiarrhythmics inhibit Na+ absorption and Cl− secretion in rabbit descending colon epithelium

Naunyn-Schmiedeberg's Archives of Pharmacology, 2005
K Turnheim, Hubert Wiener, Turnheim Klaus   +2 more
exaly  

Analysis of Implantable Cardioverter Defibrillator Therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial

Journal of Cardiovascular Electrophysiology, 2003
Richard C Klein, Merritt H Raitt, James Coromilas   +2 more
exaly  

Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry.

American Heart Journal, 2002
James R. Cook, C. Rizo-Patron, A. Curtis, A. Gillis, J. Bigger, S. Kutalek, J. Coromilas, Bradley Hofer, J. Powell, A. Hallstrom   +9 more
semanticscholar   +1 more source

Application of nonlinear and local modeling methods for 3D QSAR study of class I antiarrhythmics

Chemometrics and Intelligent Laboratory Systems, 2000
Peter Mátyus
exaly  

Antiarrhythmics Versus Implantable Defibrillators (AVID)--rationale, design, and methods.

American Journal of Cardiology, 1995
A. Hallstrom, H. Greene, D. Wyse, D. Zipes, Andrew E Epstein, M. Domanski, Eleanor Schron, A. Investigators   +7 more
semanticscholar   +1 more source

Subanalyses of secondary prevention implantable cardioverter-defibrillator trials: antiarrhythmics versus implantable defibrillators (AVID), Canadian Implantable Defibrillator Study (CIDS), and Cardiac Arrest Study Hamburg (CASH).

Current Opinion in Cardiology, 2004
O. Oseroff, E. Retyk, Andrés Bochoeyer
semanticscholar   +1 more source

Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.

American Journal of Cardiology, 1999
Riccardo Cappato
semanticscholar   +1 more source

Differential Effect of β‐Adrenergic Stimulation on the Frequency‐Dependent Electrophysiologic Actions of the New Class III Antiarrhythmics Dofetilide, Ambasilide, and Chromanol 293.

, 1997
J. Schreieck, Yanggan Wang, V. Gjini, M. Korth, B. Zrenner, A. Schömig, C. Schmitt   +6 more
semanticscholar   +1 more source

Class III antiarrhythmics and phenytoin: teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage.

Current pharmaceutical design, 2001
Bengt R. G. Danielsson, A. Sköld, F. Azarbayjani   +2 more
semanticscholar   +1 more source